Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Sep 6;19(9):e0309363. doi: 10.1371/journal.pone.0309363

Small for gestational age and age at menarche in a contemporary population-based U.S. sample

Sruchika Sabu 1,¤a,*,#, Hope Corman 2,#, Kelly Noonan 3,#, Nancy E Reichman 1,4,#, Kirsten B Kuhn 5,, Sally Radovick 1,¤b,
Editor: Inge Roggen6
PMCID: PMC11379201  PMID: 39240976

Abstract

Children born small for gestational age (SGA) may be at risk for earlier puberty and adverse long-term health sequelae. This study investigates associations between SGA and age at menarche using secondary data on 1,027 female children in a population-based U.S. birth cohort that over-sampled non-marital births, which in the U.S. is a policy-relevant population. SGA was defined as <10th percentile of weight for gestational age compared to the national U.S. distribution. We estimated unadjusted and adjusted Ordinary Least Squares (OLS) models of associations between SGA and age at menarche in years, as well as unadjusted and adjusted logistic regression models of associations between SGA and early menarche (before age 11). SGA was not significantly associated with earlier age at menarche, even when adjusting for maternal sociodemographic characteristics, prenatal smoking, and maternal pre-pregnancy overweight and obesity. Similarly, SGA was not significantly associated with the odds of menarche occurring before age 11. However, maternal non-Hispanic Black race-ethnicity, Hispanic ethnicity, and pre-pregnancy obesity all had independent associations with average earlier age at menarche and menarche before age 11. Thus, maternal risk factors appear to play more influential roles in determining pubertal development.

Introduction

Menarche is a significant developmental milestone experienced by girls, and its timing influences biological, social, and psychological development. Over the last century, many developed countries saw a rapid decrease in the average age of menarche [1]. In some countries, the decline has recently stabilized. For example, the National Center for Health Statistics reports that the average age at menarche in the United States has been about 12.5 years since 1995 [2]. However, the prevalence of early menarche continues to increase in other countries; e.g., a 2020 study found that the prevalence of early menarche (defined as occurring before 10.5 years of age in this study) increased from 1.8% in 2006 to 3.2% in 2015 in Korea [3].

Early menarche is usually defined using standard deviation, percentile, or age cutoffs, and has been variably defined as menarche at a time before the age of 10 through 12 years. Early menarche should be distinguished from premature menarche, which is defined as the onset of vaginal bleeding in girls less than 7 years of age and suggests a pathologic process [4]. Early menarche is a concerning phenomenon due to its significant ramifications for the timing of menopause [5] and its relation to obesity [6]. Further, girls with early menarche are more likely to experience depressive symptoms and engage in health risk behaviors that adversely impact health in adulthood [7], although it has not been established whether those associations are confounded by socioeconomic factors. Early menarche has also been associated with an increased risk of developing cardiovascular disease [8], asthma [9], polycystic ovarian syndrome [10], and endometriosis [11]. Because girls who experience early menarche are vulnerable to adverse outcomes, the factors that influence the age at menarche warrant investigation.

Studies have shown that being born small for gestational age (SGA) can result in long-term adverse health sequelae, including early puberty and subsequent short stature [12], obesity [13], and metabolic disorders in adulthood [14]. SGA is a heterogeneous condition that may result from diverse factors, including genetic abnormalities, maternal medical conditions, substance use, demographics, diet, pregnancy course, and past obstetric history [15]. One of the proposed mechanisms relating SGA to early menarche is a phenomenon known as “catch-up growth,” which occurs early in childhood and is associated with increased central adiposity, premature pubarche, earlier puberty, and earlier menarche [12, 13, 16].

Only a few prospective cohort studies have investigated linkages between SGA and age at menarche. In a cohort of children that were followed into adolescence in Sweden (born 1973–1977), girls that were SGA had menarche an average of 5 months earlier than girls born appropriate for gestational age (AGA) [17]. Another study in Korea that followed 30 SGA subjects (born 1988–1999) found that age at menarche did not differ from the population average; however, AGA subjects were not used as controls [18]. In the Danish Puberty Cohort (born 2000–2003), the age at menarche in girls born SGA was about 2 months earlier than that of girls born AGA [19]. In a cohort in Hong Kong (born 1997), no correlation was observed between SGA and the timing of puberty using Tanner staging rather than menarche to define puberty [20]. Recently, a Polish study found that SGA girls with catch-up growth had significantly earlier menarche than girls born AGA or SGA without catch-up growth [21]. The findings from these studies in relatively homogenous populations may not generalize to the U.S., which has a unique racial-ethnic composition. Our study adds to this body of knowledge by investigating linkages between SGA and age at menarche using data from a national U.S. birth cohort study that oversampled non-marital births, which in the U.S. are strongly associated with racial-ethnic minority status [22] and poverty [23] and accounted for 39.8 percent of U.S. births in 2022 (the latest year of data available) [24].

Materials and methods

Data

We used data from the Future of Families and Child Wellbeing (FFCWB) study, a population-based national birth cohort study of 4,898 births in large U.S. cities from 1998 to 2000 that conducted postpartum (baseline) interviews with the mothers and fathers and follow-up interviews with the parents and children at subsequent time points. Additional information was collected from the mothers’ and children’s medical records from the birth hospitalization. The availability of medical records depended primarily on the administrative processes of hospitals rather than the decisions of respondents to make their records available. Additional information was taken from interviews with the children that were conducted when they were 15 years old. We focused on children who were assigned as female at birth.

The FFCWB cohort was population-based because it used a probability sample of cities, hospitals, and births within hospitals. Non-marital births were oversampled by design; that is, marital births were no longer included when hospital-specific quotas were reached. The reason for the oversampling was that unmarried parents and their children had been underrepresented in national U.S. datasets. About three-fourths of the mothers in the study were unmarried when they gave birth [25, 26]. Because non-marital childbearing is strongly associated with poverty in the U.S., as is racial/ethnic minority status, the FFCWB sample had high fractions of poor, Black, and Hispanic parents.

The analyses were performed using de-identified third-party data that are available to the public through a restricted data use contact from the Future of Families & Child Wellbeing Study at Princeton University [27], which obtained informed consent from all participants per all relevant guidelines and regulations [26]. Data was accessed to conduct this study on August 15, 2022. The authors had no access to information identifying individual participants for this study, which did not involve data collection.

Measures

Small for gestational age (SGA)

SGA was defined as <10th percentile of sex-specific birth weight for gestational age. Gestational age was calculated as the number of completed weeks between the date of the first day of the mother’s last menstrual period (LMP) and the child’s birthday. The respondent’s birth weight for gestational age was compared to the national U.S. sex-specific reference distribution of LMP-based SGA from 1999–2000 [28] when most of the FFCWB sample members were born.

Age at menarche

Age at menarche was measured in months and was reported in the 15-year survey, in which girls were asked whether they had ever had a menstrual period and, if so, to report their age in years and months (e.g., 13 years and 2 months old) when menarche occurred. These questions were supplemented with information from girls’ diary data at age 15 and mothers’ reports about the daughters’ menarche during a 9-year survey. The information on the timing of menarche came from the 15-year survey for approximately 97 percent of cases. For approximately one-quarter of girls, we know their age at menarche in years but not the exact month. In those cases, we set the months equal to 6 and created a binary variable for missing data on months. In supplementary analyses, we dropped the cases with missing data on months. Age at menarche was also evaluated as a binary variable for whether the respondent had experienced menarche before age 11, a cut-off used in previous studies [29].

Other analysis variables

The analyses included maternal sociodemographic characteristics, which the mother reported in her postpartum survey. They included her age, race-ethnicity, foreign-born status, education, marital status, parity (first birth vs. higher-order birth), and whether the delivery was insured by Medicaid (a government-funded health insurance program available to low-income pregnant women in the U.S.) (Table 1). Some analyses additionally included pre-pregnancy obesity, pre-pregnancy overweight, and prenatal cigarette smoking. Pre-pregnancy obesity and overweight were based on the height and pre-pregnancy weight recorded in the mother’s medical record, which was used to compute body mass index (weight in kilograms divided by height in meters squared) and classify mothers as overweight or obese using established ranges (25.0 to <30 indicating overweight; 30 or higher indicating obese) [30]. The 14% of mothers with missing data on pre-pregnancy weight were coded as having been normal or underweight. We also controlled for a binary indicator for missing data on pre-pregnancy weight. We assessed sensitivity to excluding the cases with missing pre-pregnancy weight data. For prenatal smoking, we coded the mother as ever having smoked cigarettes during pregnancy if there was an indication of such in the medical records or the mother indicated a positive number in response to a question in the postpartum interview about how many cigarettes she smoked per day during the pregnancy. Indicators were included in the models of SGA in months for missing months (i.e., the respondent reported her age in whole years when menarche began).

Table 1. Outcomes and sample characteristics, overall and by SGA.
Full Sample Not SGA SGA P-value
Timing of menarche
 Age, mean months (s.d.) 147.5 (15.8) 147.7 (15.6) 146.4 (17.3) 0.41
 Before age 11 0.14 0.14 0.19 0.15
Maternal sociodemographic characteristics
Race-ethnicity
 Non-Hispanic White 0.21 0.21 0.19 0.72
 Non-Hispanic Black 0.50 0.48 0.60 0.01
 Hispanic 0.27 0.28 0.19 0.04
 Other race 0.03 0.03 0.02 0.35
Education
 High school graduate 0.67 0.68 0.62 0.16
 Less than high school 0.33 0.32 0.38 0.16
Nativity
 US born 0.86 0.85 0.92 0.06
 Foreign born 0.14 0.15 0.08 0.06
Age, mean years
 < 20 0.17 0.17 0.23 0.10
 20–34 0.74 0.75 0.68 0.10
 35+ 0.09 0.08 0.09 0.76
Relationship with child’s father
 Married 0.24 0.26 0.14 0.00
 Cohabiting but not married 0.38 0.38 0.37 0.94
 Neither married nor cohabiting 0.38 0.37 0.49 0.01
Parity
 First birth 0.39 0.38 0.45 0.15
 Higher-order birth 0.61 0.62 0.55 0.15
Health insurance for birth
 Medicaid 0.64 0.63 0.76 0.00
 Other 0.36 0.37 0.24 0.00
Other maternal variables
Pre-pregnancy weight
 Obese 0.24 0.25 0.19 0.22
 Overweight (but not obese) 0.18 0.19 0.18 0.85
 Normal or underweight 0.58 0.57 0.63 0.23
Prenatal smoking
 Any 0.2300 0.21 0.44 <0.01
 None 0.77 0.79 0.56 <0.01
N 1,003 885 118

Notes: SGA = small-for-gestational age = <10th percentile of sex-specific birth weight for gestational age; s.d. = standard deviation. SGA was based on birth weight and LMP-based gestational age and compared to the national U.S. sex-specific distribution of LMP-based SGA from 1999–2000. Figures are column proportions unless indicated otherwise. All maternal characteristics were assessed from the postpartum interviews. Pre-pregnancy obesity, pre-pregnancy overweight, and smoking were assessed from information in the mother’s medical charts from the birth hospitalization. Calculations are based on sample used for analyses of age at menarche in months. P-values are for differences by SGA at 5% level using a two-tailed t-test (statistically significant p-values in bold).

Study sample

Of the 2,295 female singleton newborns in the FFCWB study, 562 had no available medical record data, and another 300 had missing data on birth weight or the date of the mother’s last menstrual period, both of which were used to compute small for gestational age. Of the 1,433 remaining cases, 387 had no information on the timing of menarche. This resulted in an eligible sample of 1,036 cases (Fig 1). Of those, 9 had incomplete data on other analysis variables, resulting in a sample of 1,027 cases for analyses of menarche before age 11. From the 1,027 cases, 16 who had not yet experienced menarche and 8 who had missing information on the timing of menarche (but it was known that they had menarche prior to age 11) were excluded from analyses of menarche in months, resulting in a sample of 1,003 for that outcome.

Fig 1. Derivation of analysis sample.

Fig 1

Statistical analysis

First, we compared our analysis sample of 1,003 to the cases in the full cohort of 2,295 that were not in that sample using two-tailed t-tests. Second, we documented age at menarche and maternal characteristics in the analysis sample, both overall and by SGA status. Third, we estimated unadjusted and adjusted linear Ordinary Least Squares (OLS) models of associations between SGA and age at menarche in months. Fourth, we estimated unadjusted and adjusted logistic regression models of associations between SGA and menarche before age 11.

Finally, we estimated sets of supplementary models that alternatively used a different cutoff for SGA (the 25% percentile of birth weight for gestational age) that a recent study found was associated with developmental concerns [31], added a control for the number of completed weeks of gestation, restricted the sample to full term births (37–41 weeks), restricted the sample to children that weighed > 2500 grams at birth, restricted the sample for both outcomes to girls who reported month of menarche as well as the year, used the smaller sample of 1,003 in the logistic regression models, restricted the sample to cases with non-missing pre-pregnancy weight, and used inverse probability weights to account for sample loss from the initial sample of 2,295 cases. We also estimated models that interacted SGA with weight gain between birth and 1 year to assess potential differential associations between SGA and age at menarche by a measure of postnatal catch-up growth that was available in the data.

In all sets of models, the first adjusted model included maternal sociodemographic characteristics, and the second further included maternal pre-pregnancy obesity, overweight, and prenatal smoking. All estimates are presented with 95% confidence intervals.

Analyses were conducted using Stata Version 18 (Stata Corp, College Station, TX). This study was approved by the Institutional Review Boards of Rutgers and Princeton Universities. All data analysis was conducted at Princeton University.

Results

The mothers of children in the analysis sample did not differ significantly from those who were not in the sample based on race, ethnicity, marital status, age, first birth, and Medicaid coverage for the birth, but they were less likely to be foreign-born and to smoke during the prenatal period, had more education, and had higher rates of overweight and obesity (S1 Table).

Approximately 12% of the subjects were SGA (118/1,003 = 11.8%). The average age at menarche was 147.5 months (12.3 years); 14% of participants had menarche before age 11 (Table 1). There was no difference in age at menarche between girls who were born SGA vs. those who were not born SGA. Half (50%) of the mothers were non-Hispanic Black, a quarter (27%) were Hispanic, and a third (33%) had less than a high school education. Almost two-thirds (64%) of the births were insured by Medicaid. A quarter (24%) of mothers were married, and 38% were cohabiting but not married at the time of the birth, reflecting the oversampling of nonmarital births in the FFCWB study. The sociodemographic characteristics of the sample reflect the strong associations between nonmarital childbearing, poverty, and racial-ethnic minority status in the United States [22, 23]. Further, 24% of the mothers were obese prior to pregnancy, 18% were overweight but not obese prior to pregnancy, and 23% smoked during pregnancy.

Compared to girls who were not SGA, those who were SGA were more likely to have mothers who were non-Hispanic Black (60% vs. 48%), had Medicaid-financed births (76% vs. 63%), and smoked during pregnancy (44% vs. 21%), and were less likely to have mothers who were Hispanic (19% vs. 28%) and married (14% vs. 26%).

Age at menarche in months

In the unadjusted linear regression model, SGA was not significantly associated with earlier age at menarche (Table 2; OLS coef.: -1.27; CI: -4.54, 2.00). The estimate was similar in linear models that adjusted for maternal socioeconomic characteristics (OLS coef.: -1.34; CI: -4.64, 1.97) and that further adjusted for pre-pregnancy obesity, pre-pregnancy overweight, and prenatal smoking (OLS coef.: -1.18; CI: -4.55, 2.19).

Table 2. Ordinary least squares estimates of associations between SGA and age at menarche in months and between maternal characteristics and age at menarche.

Unadjusted Adjusted for maternal demographics Adjusted for maternal demographics, pre-pregnancy obesity, pre-pregnancy overweight, and prenatal smoking
OLS coefficient OLS coefficient OLS coefficient
(95% CI) (95% CI) (95% CI)
SGA -1.27 -1.34 -1.18
(-4.54, 2.00) (-4.64, 1.97) (-4.55, 2.19)
Race-ethnicity
 Non-Hispanic White ref ref
 Non-Hispanic Black -4.82 -4.50
(-7.38, -2.26) (-7.14, -1.86)
 Hispanic -6.70 -6.66
(-9.79, -3.61) (-9.82, -3.51)
 Other -2.81 -2.84
(-9.37, 3.74) (-9.38, 3.70)
Education
 High school graduate -1.37 -1.69
(-3.73, 1.00) (-4.07, 0.69)
 Less than high school ref ref
Nativity
 US born ref
 Foreign born 0.46 0.01
(-2.82, 3.75) (-3.29, 3.31)
Age
 < 20 years 0.27 -0.66
(-3.80, 4.35) (-4.75, 3.43)
 20–34 0.72 0.32
(-2.40, 3.85) (-2.84, 3.49)
 35+ ref ref
Relationship with child’s father
 Married 1.70 1.49
(-1.23, 4.64) (-1.42, 4.40)
 Cohabiting but not married -0.47 -0.38
(-2.78, 1.83) (-2.69, 1.93)
 Neither married nor cohabiting ref ref
Parity
 First birth 0.09 -0.25
(-2.01, 2.19) (-2.37, 1.87)
 Second of higher order birth ref ref
Health insurance for birth
 Medicaid 1.49 1.45
(-0.80, 3.79) (-0.86, 3.75)
 Other ref ref
Pre-pregnancy weight
 Obese -3.16
(-5.78, -0.54)
 Overweight -2.90
(-5.52, -0.28)
 Normal or underweight ref
Prenatal smoking
 Any -1.62
(-4.15, 0.91)
 None ref

Notes: OLS = Ordinary Least Squares. SGA = small-for-gestational age = <10th percentile of sex-specific birth weight for gestational age. (N = 1,003). SGA was based on birth weight and last menstrual period (LMP)-based gestational age and compared to the national U.S. sex-specific distribution of LMP-based SGA from 1999–2000. All models included a binary indicator for missing data on age in menarche in months (i.e., the respondent reported her age at menarche but not in months in addition to her years of age) and the fully adjusted model included a binary indicator for missing pre-pregnancy weight. Statistically significant estimates at p < .05 are in bold.

In the fully adjusted model, having a non-Hispanic Black mother was associated with 4.5 months (.38 years) earlier menarche (OLS coef.: -4.50; CI: -7.14, -1.86), and having a Hispanic mother was associated with 6.7 months (.56 years) earlier menarche (OLS coef.: -6.66; CI: -9.82, -3.51). Maternal pre-pregnancy obesity (OLS coef.: -3.16; CI: -5.78, -0.54) and overweight (OLS coef.: -2.90; CI: -5.52, -0.28) were also independently associated with earlier menarche, by .26 and .24 years, respectively.

Menarche before age 11

In the unadjusted logistic regression model, SGA was not significantly associated with the odds of menarche before age 11 (Table 3; OR 1.46; CI: 0.89, 2.42). The estimates were similar and never statistically significant when adjusting for maternal sociodemographic characteristics (AOR: 1.45; CI: 0.86, 2.46) or when further adjusting for pre-pregnancy obesity, pre-pregnancy overweight, and prenatal smoking (AOR: 1.47; CI: 0.85, 2.52). In the fully adjusted logistic regression model, maternal non-Hispanic Black race-ethnicity was associated with twice the odds (AOR: 2.06; CI: 1.12, 3.79), Hispanic ethnicity was associated with over two times the odds (AOR: 2.28; CI: 1.15, 4.49), and pre-pregnancy obesity was associated with 64% higher odds (AOR: 1.64; CI: 1.02, 2.62) of menarche before age 11.

Table 3. Logistic regression estimates of associations between SGA and menarche before age 11 and between maternal characteristics and menarche before age 11.

Unadjusted Adjusted for maternal demographics Adjusted for maternal demographics, pre-pregnancy obesity, pre-pregnancy overweight, and prenatal smoking
OR AOR AOR
(95% CI) (95% CI) (95% CI)
SGA 1.46 1.45 1.47
(0.89, 2.42) (0.86, 2.46) (0.85, 2.52)
Race-ethnicity
 Non-Hispanic White ref ref
 Non-Hispanic Black 2.21 2.06
(1.22, 4.03) (1.12, 3.79)
 Hispanic 2.38 2.28
(1.22, 4.66) (1.15, 4.49)
 Other 2.46 2.42
(0.82, 7.39) (0.80, 7.32)
Education
 High school graduate 1.19 1.23
(0.78, 1.82) (0.80, 1.89)
 Less than high school ref ref
Nativity
 US born ref ref
 Foreign born 0.88 0.93
(0.49, 1.59) (0.52, 1.68)
Age
 < 20 years 1.70 1.90
(0.69, 4.20) (0.76, 4.72)
 20–34 1.44 1.50
(0.66, 3.15) (0.68, 3.27)
 35+ ref ref
Relationship with child’s father
 Married 0.77 0.77
(0.43, 1.38) (0.43, 1.38)
 Cohabiting but not married 1.10 1.10
(0.75, 1.63) (0.74, 1.63)
 Neither married not cohabiting ref ref
Parity
 First birth 0.97 1.02
(0.66, 1.43) (0.69, 1.52)
 Second or higher order birth ref ref
Health insurance for birth
 Medicaid 0.87 0.88
(0.57, 1.34) (0.57, 1.36)
 Other ref ref
Pre-pregnancy weight
 Obese 1.64
(1.02, 2.62)
 Overweight 1.55
(0.93, 2.57)
 Normal or underweight ref
Prenatal smoking
 Any 1.09
(0.70, 1.69)
 None ref

Notes: AOR = adjusted odds ratio. OR = odds ratio. SGA = small-for-gestational age = <10th percentile of sex-specific birth weight for gestational age. (N = 1,027). SGA was based on birth weight and LMP-based gestational age and compared to the national U.S. sex-specific distribution of LMP-based SGA from 1999–2000. Fully adjusted models included a binary indicator for missing data on pre-pregnancy weight. Statistically significant estimates at p < .05 are in bold.

Supplemental analyses

In models that used a 25th percentile cutoff to define SGA, SGA was not significantly associated with age at menarche in months or menarche before age 11 (not shown). Models that alternatively included a control for gestational age in weeks, restricted the sample to full-term births (37–41 weeks), restricted the sample to children who weighed > 2500 grams at birth, restricted the sample for both outcomes to girls who reported month of menarche as well as the year, used the smaller sample of 1,003 in the logistic regression models, restricted the sample to cases that had non-missing data on pre-pregnancy weight, or used inverse probability weights to account for missing observations all produced estimates that were very similar to those in Tables 2 and 3 (not shown). In supplementary models that interacted weight gain between birth and age 1 with SGA, we found no significant interactions. However, weight gain was associated with earlier menarche in those models (e.g., OLS coeff: -.75; CI: -1.36, -0.15) in the fully adjusted model for age at menarche in months and AOR: 1.13; CI: 1.02, 1.26 in the fully adjusted model for menarche before age 11) (not shown in tables).

Discussion

In this prospective study of a population-based U.S. birth cohort that included large proportions of subjects with racial-ethnic minority status and low socioeconomic status, SGA was not significantly associated with earlier age at menarche. As such, this manuscript contributes valuable data points to the literature that has found mixed results for associations between SGA and pubertal development. However, maternal Black race, Hispanic ethnicity, and pre-pregnancy obesity had strong independent associations with daughters’ earlier age at menarche and with menarche before age 11 in this population. For example, girls with non-Hispanic Black mothers had menarche about a third of a year earlier than those with non-Hispanic White mothers, girls with Hispanic mothers had menarche over half a year earlier than those with non-Hispanic White mothers, and girls whose mothers were obese or overweight had menarche about a quarter of a year earlier than those whose mothers were not obese or overweight. These findings corroborate evidence from more racially-ethnically homogeneous populations of associations between both minority race-ethnicity and maternal obesity and earlier menarche in offspring [3234].

It should be noted that the contributions of race-ethnicity and BMI are challenging to disentangle as those factors are integrated in a complex manner; for example, racial-ethnic compositions of communities have been associated with individual-level BMI independent of individual-level race-ethnicity [35]. A multi-center U.S. study found that child BMI, which is associated with maternal BMI [36], had a stronger association with age at menarche than race-ethnicity did [37], and another recent study in California found that childhood obesity was associated with earlier menarche, but the magnitude of the association varied by race-ethnicity [38]. In moving towards race-conscious medicine, the relationship between race-ethnicity and obesity is understood to be a consequence of environmental racism rather than race pathologization [39]. For example, youth obesity is known to be associated with lower socioeconomic status and food insecurity [40], and early puberty or menarche is known to be associated with early life stress and potential environmental chemical exposures from marketed products [4143]. All of these adverse exposures are disproportionately experienced by members of racial-ethnic minority groups [39]. Although we studied a population that over-sampled non-marital births and were able to control for many socioeconomic factors, we could not account for all potentially relevant environmental, social, and perhaps genetic or epigenetic factors in our study.

As discussed, SGA or low birth weight models propose that “catch-up growth” leads to increased adiposity and subsequent earlier puberty [44]. Adiposity may be defined in terms of body composition, biochemical changes, abdominal obesity, or weight and weight velocity. In the Danish cohort noted earlier, the absence or presence of catch-up growth in SGA children significantly contributed to age at menarche, such that those without catch-up growth had later menarche [19]. Further, a multi-center U.S. cohort study showed that independent of AGA or SGA status, more significant weight gain in early childhood was associated with earlier menarche and pubertal development [37]. Interestingly, one study found that increased total body fat led to slower progression of breast development but faster achievement of menarche [45]. Unfortunately, we were unable to fully incorporate the potential role of the child’s weight in this study because the children’s weights and heights were not consistently measured in the FFCWB study. However, our supplementary analyses that interacted SGA with first-year weight gain suggested no interactive associations, although weight gain was independently associated with earlier menarche. Additionally, we could not account for maternal age at menarche, which has been associated with changes in offspring BMI [46]. Our study instead focused on maternal factors known to be associated with elevated child BMI, such as race-ethnicity [47] and maternal pre-pregnancy obesity [36].

Moreover, increased adiposity is a complex phenomenon studied in SGA models, and ideally, it would not be evaluated solely using indirect measures such as BMI. A longitudinal cohort study using multiple adiposity indicators including BMI, waist circumference, and body composition found that increased prepubertal adiposity was associated with an increased risk of earlier puberty onset [48]. Also, adiposity measured directly as body composition had a stronger relationship to earlier puberty onset than indirect measures (BMI or waist circumference) [48]. Biochemical characteristics of increased adiposity were studied in SGA girls, showing they were more likely to develop hyperinsulinism, hypoadiponectinemia, hyperleptinemia, dyslipidemia, lower sex hormone binding globulin, higher dehydroepiandrosterone sulfate, and advanced bone maturation [13]. We could not distinguish between adiposity measured from body composition versus BMI using our data.

Strengths of our study include the population-based U.S. cohort and inclusion of rich control variables, including maternal race-ethnicity, other sociodemographic characteristics, and maternal pre-pregnancy body weight. Because the FFCWB study oversampled non-marital births by design, it is not representative of the U.S. population. Indeed, 11.7% of the subjects in our sample were SGA, which is expectedly higher than the national rate of 10%. However, children of unmarried parents represent a policy-relevant population in the U.S. because of their disproportionate risks of developmental problems as a result of socioeconomic risk factors, including racial-ethnic minority status and poverty.

Although we found no significant associations between SGA and menarche before age 11, the magnitudes of the ORs were not trivial, and it is possible that with a larger sample the associations would have been statistically significant. Other limitations include loss to follow-up; the mothers of the children in our analysis sample were less likely to be foreign-born and to smoke during the prenatal period and had higher education and rates of overweight and obesity compared to mothers of children not in our analysis sample, which could bias the estimates, although the expected direction of bias is not clear. Also, our study data uses self-reported age at menarche, and many subjects only knew their approximate age in years instead of a specific date. Although menarche before age 11 is a frequently used cutoff to define early menarche, we could not use stricter cutoffs, such as before age 10, since too few girls in our sample experienced menarche within that age range for meaningful analysis. There is evidence that the age of puberty is decreasing for males as it has been for females [49], but we were not able to investigate associations between SGA and puberty in males with our data since there was no survey marker obtained for male puberty. In addition, causality cannot be firmly established in any observational study.

In a national U.S. birth cohort that included large proportions of subjects with racial-ethnic minority status, SGA status was not associated with girls’ age at menarche, but maternal race-ethnicity and pre-pregnancy obesity were strongly and independently associated with daughters’ earlier age at menarche. Additional insight can be gained from future prospective studies using body composition analysis to measure adiposity and explore the relationship between SGA, race-ethnicity, and age at menarche.

Supporting information

S1 Table. Comparison of analysis sample to singleton female births not in the sample.

Notes: Calculations are based on sample used for analyses of age at menarche in months. P-values are for differences between those in the sample for age at menarche in months and singleton females not in that sample at the 5% level using a two-tailed t-test (statistically significant p-values in bold).

(DOCX)

pone.0309363.s001.docx (17.1KB, docx)

Data Availability

Data availability statement: We used third-party data that are available to the public through a restricted data use contract from the Future of Families & Child Wellbeing Study at Princeton University. Details about the application process can be found at: https://ffcws.princeton.edu/restricted.

Funding Statement

Support for this research was provided by award UL1TR003017 from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health and grant 74260 from the Robert Wood Johnson Foundation through its support of the Child Health Institute of New Jersey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Papadimitriou A. The evolution of the age at menarche from prehistorical to modern times. J Pediatr Adolesc Gynecol. 2016;29(6):527–530. doi: 10.1016/j.jpag.2015.12.002 [DOI] [PubMed] [Google Scholar]
  • 2.Martinez GM. National Health Statistics Reports [Internet]. CDC.gov. 2010. [Cited 2024 July 20]. www.cdc.gov/nchs/data/nhsr/nhsr146-508.pdf.
  • 3.Seo MY, Kim SH, Juul A, Park MJ. Trend of menarcheal age among Korean girls. J Korean Med Sci. 2020;35(49):e406. doi: 10.3346/jkms.2020.35.e406 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kota AS, Sehar Ejaz. Precocious Puberty [Internet]. Nih.gov. StatPearls Publishing; 2019. [Cited 2024 July 20]. https://www.ncbi.nlm.nih.gov/books/NBK544313/. [PubMed]
  • 5.Mishra GD, Nirmala P, Dobson AJ, Chung HF, Anderson D, Kuh D et al. Early menarche, nulliparity, and the risk for premature and early natural menopause. Hum Reprod. 2017;32(3):679–686. doi: 10.1093/humrep/dew350 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bralić I, Tahrivoć H, Matanić D, Vrdoljak O, Stojanović-Spehar S, Kovacić V, et al. Association of early menarche age and overweight/obesity. J Pediatr Endocrinol Metab. 2012;25(1–2):57–62. doi: 10.1515/jpem-2011-0277 [DOI] [PubMed] [Google Scholar]
  • 7.Mendle J, Ryan RM, McKone KMP. Age at menarche, depression, and antisocial behavior in adulthood. Pediatrics. 2018;141(1):e20171703. doi: 10.1542/peds.2017-1703 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Luijken J, van der Schouw YT, Mensink D, Onland-Moret NC. Association between age at Menarche and Cardiovascular Disease: A systematic review on risk and potential mechanisms. Maturitas. 2017;104:96–116. doi: 10.1016/j.maturitas.2017.07.009 [DOI] [PubMed] [Google Scholar]
  • 9.Al-Sahab B, Hamadeh MJ, Ardern CI, Tamim H. Early menarche predicts incidence of asthma in early adulthood. Am J Epidemiol. 2010;173(1):64–70. doi: 10.1093/aje/kwq324 [DOI] [PubMed] [Google Scholar]
  • 10.Caroll J, Saxena R, Welt CK. Environmental and Genetic Factors Influence Age at Menarche in Women with Polycystic Ovary Syndrome. J Pediatr Endocrinol Metab. 2012;25(5–6):459–466. doi: 10.1515/jpem-2012-0047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Lu MY, Niu JL, Liu B. The risk of endometriosis by early menarche is recently increased: A meta-analysis of literature published from 2000 to 2020. Arch Gynecol Obstet. 2023;307(1):59–69. doi: 10.1007/s00404-022-06541-0 [DOI] [PubMed] [Google Scholar]
  • 12.Ibáñez L, Ferrer A, Marcos MV, Hierro FR, de Zegher F. Early puberty: rapid progression and reduced final height in girls with low birth weight. Pediatrics. 2000;106(5):e72. doi: 10.1542/peds.106.5.e72 [DOI] [PubMed] [Google Scholar]
  • 13.Ibáñez L, Lopez-Bermejo A, Diaz M, de Zegher F. Catch-up growth in girls born small for gestational age precedes childhood progression to high adiposity. Fertil Steril. 2011;96(1):220–223. doi: 10.1016/j.fertnstert.2011.03.107 [DOI] [PubMed] [Google Scholar]
  • 14.Goedegebuure WJ, Van der Steen M, Smeets CCJ, Kerkhof GF, Hokken-Koelega ACS. SGA-born adults with postnatal catch-up have a persistently unfavourable metabolic health profile and increased adiposity at age 32 years. Eur J Endocrinol. 2022;187(1):15–26. doi: 10.1530/EJE-21-1130 [DOI] [PubMed] [Google Scholar]
  • 15.McCowan L, Horgan RP. Risk factors for small for gestational age infants. Best Practice & Research Clinical Obstetrics & Gynaecology. 2009;23(6):779–793. [DOI] [PubMed] [Google Scholar]
  • 16.Ibáñez L, Ong K, Dunger DB, de Zegher F. Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. J Clin Endocrinol Metab. 2006;91(6):2153–2158. doi: 10.1210/jc.2005-2778 [DOI] [PubMed] [Google Scholar]
  • 17.Persson I, Ahlsson F, Ewald U, Tuvemo T, Qingyuan M, von Rosen D, et al. Influence of perinatal factors on the onset of puberty in boys and girls: implications for interpretation of link with risk of long term diseases. Am J Epidemiol. 1999;150(7):747–755. doi: 10.1093/oxfordjournals.aje.a010077 [DOI] [PubMed] [Google Scholar]
  • 18.Shim YS, Park HK, Yang S, Hwang IT. Age at menarche and adult height in girls born small for gestational age. Ann Pediatr Endocrinol Metab. 2013;18(2):76–80. doi: 10.6065/apem.2013.18.2.76 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Hvidt JJ, Brix N, Ernst A, Lauridsen LLB, Ramlau-Hansen CH. Size at birth, infant growth, and age at pubertal development in boys and girls. Clin Epidemiol. 2019;11:873–883. doi: 10.2147/CLEP.S217388 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hui LL, Leung GM, Wong MY, Lam TH, Schooling CM. Small for gestational age and age at puberty: Evidence from Hong Kong’s “children of 1997” Birth cohort. Am J Epidemiol. 2012;176(9):785–793. doi: 10.1093/aje/kws159 [DOI] [PubMed] [Google Scholar]
  • 21.Durda-Masny M, Stróżewska W, Szwed A. Catch-Up Growth as a Risk Factor for Rapid Weight Gain, Earlier Menarche and Earlier Pubertal Growth Spurt in Girls Born Small for Gestational Age (SGA)-A Longitudinal Study. Int J Environ Res Public Health. 2022;19(24):16808. doi: 10.3390/ijerph192416808 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Semega J, Kollar M, Shrider EA, Creamer J. Income and Poverty in the United States: 2019 [Internet]. The United States Census Bureau. 2020. https://www.census.gov/library/publications/2020/demo/p60-270.html.
  • 23.Solomon-Fears C. Nonmarital Births: An Overview. Congressional Research Service. 2014. https://sgp.fas.org/crs/misc/R43667.pdf.
  • 24.Osterman M, Hamilton B, Martin J, Driscoll A, Valenzuela C. Births: Final Data for 2022. National Vital Statistics Reports [Internet]. 2024;73. https://www.cdc.gov/nchs/data/nvsr/nvsr73/nvsr73-02.pdf. [PubMed]
  • 25.Data and documentation. 2023 [cited 20 Jun 2024]. In: Future of Families & Child Wellbeing Study [Internet]. https://fragilefamilies.princeton.edu/documentation.
  • 26.Reichman NE, Teitler JO, Garfinkel I, McLanahan SS. Fragile Families: sample and design. Children and Youth Services Review. 2001. Apr;23(4–5):303–326. [Google Scholar]
  • 27.Restricted Use Contract Data [Internet]. Future of Families and Child Wellbeing Study. [cited 2024 Jul 20]. https://ffcws.princeton.edu/restricted.
  • 28.Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr. 2003;3:6. doi: 10.1186/1471-2431-3-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mishra GD, Pandeya N, Dobson AJ, Chung HF, Anderson D, Kuh D, et al. Early menarche, nulliparity and the risk for premature and early natural menopause. Human Reproduction [Internet]. 2017 Jan 24; https://academic.oup.com/humrep/article/32/3/679/2937790. [DOI] [PMC free article] [PubMed]
  • 30.Defining adult overweight & obesity. 2022 Jun 3 [cited 2 April 2024]. In: Centers for Disease Control and Prevention [Internet]. https://www.cdc.gov/obesity/basics/adult-defining.html.
  • 31.Adanikin A, Lawlor DA, Pell JP, Nelson SM, Smith GCS, Iliodromiti S. Association of birthweight centiles and early childhood development of singleton infants born from 37 weeks of gestation in Scotland: A population-based cohort study. PLOS Medicine. 2022. Oct 11;19(10):e1004108. doi: 10.1371/journal.pmed.1004108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Brix N, Ernst A, Lauridsen LLB, Arah OA, Nohr EA, Olsen J, et al. Maternal pre-pregnancy obesity and timing of puberty in sons and daughters: a population-based cohort study. Int J Epidemiol. 2019;48(5):1684–1694. doi: 10.1093/ije/dyz125 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Keim SA, Branum AM, Klebanoff MA, Zemel BS. Maternal body mass index and daughters’ age at menarche. Epidemiology. 2009;20(5):677–681. doi: 10.1097/EDE.0b013e3181b093ce [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Rosenfield RL, Lipton RB, Drum ML. Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index. Pediatrics. 2009;123(1):84–88. doi: 10.1542/peds.2008-0146 [DOI] [PubMed] [Google Scholar]
  • 35.Kirby JB, Liang L, Chen HJ, Wang Y. Race, place, and obesity: the complex relationships among community racial/ethnic composition, individual race/ethnicity, and obesity in the United States. Am J Public Health. 2012;102(8):1572–1578. doi: 10.2105/AJPH.2011.300452 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Heslehurst N, Vieira R, Akhter Z, Bailey H, Slack E, Ngongalah L, et al. The association between maternal body mass index and child obesity: A systematic review and meta-analysis. PLoS Med. 2019;16(6):e1002817. doi: 10.1371/journal.pmed.1002817 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Biro FM, Pajak A, Wolff MS, Pinney SM, Windham GC, Galvez MP, et al. Age of Menarche in a Longitudinal US Cohort. J Pediatr Adolesc Gynecol. 2018;31(4):339–345. doi: 10.1016/j.jpag.2018.05.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Aghaee S, Deardorff J, Quesenberry CP, Greenspan LC, Kushi LH, Kubo A. Associations Between Childhood Obesity and Pubertal Timing Stratified by Sex and Race/Ethnicity. Am J Epidemiol. 2022;191(12):2026–2036. doi: 10.1093/aje/kwac148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Osinubi A (Ade), Lewis-de los Angeles CP, Poitevien P, Topor LS. Are Black Girls Exhibiting Puberty Earlier? Examining Implications of Race-Based Guidelines. Pediatrics. 2022. Jul 26;150(2). doi: 10.1542/peds.2021-055595 [DOI] [PubMed] [Google Scholar]
  • 40.Tester JM, Xiao L, Tinajero-Deck L, Juarez L, Rosas LG. Food Insecurity Influences Weight Trajectory in Children with Obesity. Childhood Obesity. 2022. Feb 15. doi: 10.1089/chi.2021.0311 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Ruttle PL, Shirtcliff EA, Armstrong JM, Klein MH, Essex MJ. Neuroendocrine coupling across adolescence and the longitudinal influence of early life stress. Dev Psychobiol. 2015; 57(6):688–704. doi: 10.1002/dev.21138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.James-Todd T, Terry MB, Rich-Edwards J, Deierlein A, Senie R. Childhood hair product use and earlier age at menarche in a racially diverse study population: a pilot study. Ann Epidemiol. 2011;21(6):461–465. doi: 10.1016/j.annepidem.2011.01.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.McDonald JA, Tehranifar P, Flom JD, Terry MB, James-Todd T. Hair product use, age at menarche and mammographic breast density in multiethnic urban women. Environ Health. 2018;17(1):1. doi: 10.1186/s12940-017-0345-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Nam HK, Lee KH. Small for gestational age and obesity: epidemiology and general risks. Ann Pediatr Endocrinol Metab. 2018;23(1):9–13. doi: 10.6065/apem.2018.23.1.9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ortega MT, McGrath JA, Carlson L, Flores Poccia V, Larson G, Douglas C, et al. Longitudinal Investigation of Pubertal Milestones and Hormones as a Function of Body Fat in Girls. J Clin Endocrinol Metab. 2021. May 13;106(6):1668–1683. doi: 10.1210/clinem/dgab092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Wang H, Zhang Y, Tian Y, Li F, Yan C, Wang H, et al. Maternal age at menarche and offspring body mass index in childhood. BMC Pediatr. 2019;19(1):312. doi: 10.1186/s12887-019-1659-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Liu B, Du Y, Wu Y, Snetselaar LG, Wallace RB, Bao W. Trends in obesity and adiposity measures by race or ethnicity among adults in the United States 2011–18: population based study. BMJ. 2021;372:n365. doi: 10.1136/bmj.n365 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Li Y, Ma T, Ma Y, Gao D, Chen L, Chen M, et al. Adiposity Status, Trajectories, and Earlier Puberty Onset: Results From a Longitudinal Cohort Study. J Clin Endocrinol Metab. 2022;107(9):2462–2472. doi: 10.1210/clinem/dgac395 [DOI] [PubMed] [Google Scholar]
  • 49.Brix N, Ernst A, Lauridsen LLB, Parner E, Støvring H, Olsen J, et al. Timing of puberty in boys and girls: A population-based study. Paediatr Perinat Epidemiol. 2019. Jan;33(1):70–78. doi: 10.1111/ppe.12507 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Inge Roggen

17 May 2024

PONE-D-24-13471Small for gestational age and age at menarche in a contemporary population-based U.S. samplePLOS ONE

Dear Dr. Sabu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please find the reviewer's remarques below.

Please submit your revised manuscript by Jul 01 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Inge Roggen, M.D., Ph.D.

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

“Support for this research was provided by award UL1TR003017 from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health and grant 74260 from the Robert Wood Johnson Foundation through its support of the Child Health Institute of New Jersey.”

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The article entitled “Small for gestational age and age at menarche in a contemporary population-based US sample” tested the hypothesis that SGA girls experience earlier menarche. Prior reports of racially homogenous populations have yielded mixed results. This analysis of a largely minority racial/ethnic population showed that maternal factors such as race/ethnicity and obesity influenced age of menarche, rather than SGA status. The data provides valuable information to add to our understanding of factors that influence pubertal onset.

Specific comments:

1. Please provide more context to the FFCWB study, that may explain the demographic of the study population.

2. The paragraph describing SGA (lines 113 to 125) was confusing. Line 114 – please clarify. Are the authors referring to determination of the gestational age? It’s also unclear why two different methods were needed to define SGA. subjects used the LMP vs the records-based measure.

3. Lines 177/178: Is it the controls that were limited to births that were NOT low birth weight?

4. In Results, I recommend describing the difference in race/ethnicity between SGA vs not SGA.

5. Substantial discussion was given to the effect of obesity on early menarche but there was almost no discussion given for the effect of race/ethnicity on the same. Please elaborate on the current understanding of the relationship between race/ethnicity and pubertal timing (including if relevant, early childhood stress, environmental racism, Pediatrics (2022) 150 (2): e2021055595. https://doi.org/10.1542/peds.2021-055595).

Reviewer #2: The Authors hereby report the menarche onset in a pediatric cohort of small for gestational age females. The data are of interest and the cohort has a quite adequate dimension.

There are two main concerns about this paper:

- Table 1 should be moved into the Results sections, p column should be added in the right and not reported in legend

- Why Authors chose 11 years old as a cut off for menarche? Precious menarche is considered as before 10 years-old, thus all considerations about whether SGA newborn females have precocious menarche more frequently rather than non-SGA should be done considering the 10 years-old cut-off.

Reviewer #3: Well written with statistics supporting the results. Also the arguments and rationale is well supported with references . Population sample is also presentation of contemporary US population. Overall good addition to the current literature.

Reviewer #4: General comments:

Sources of variation in age at menarche are a useful focus of investigation. The authors did not find associations between SGA and age at menarche. They did identify a number of other maternal factors related to age at menarche. The data are overall presented clearly, though there are some opportunities to improve formatting and readability suggested below, as well as questions regarding some of the statements (e.g., when the authors compare the value of two coefficients).

Did the authors have any other health information about the girls at follow up (e.g., BMI) that also could yield more information, even if they did not have information about catch-up growth patterns?

Sex differences are also interesting – can the authors also speculate as to the differences, if any, between maternal factors and pubertal outcomes in female infants as compared to male infants?

Section-specific comments:

Abstract:

The database consisting of mostly of non-marital births may not be representative of the U.S. population; the authors should comment in the Discussion on how their results may differ. That said, with this current focus, the database may teach us more about children deserving of additional study.

The authors describe “early menarche” as before age 11 years. Care should be taken to distinguish between “early menarche” (variation of typical) and “premature menarche” (implying the possibility of pathology).

If the difference was not statistically significant, then the authors should not write “SGA was associated with slightly earlier menarche” which implies some meaningful difference. Instead, they can write, e.g., “We did not detect a difference.”

The authors conclude that maternal non-Hispanic black race-ethnicity, Hispanic ethnicity, and pre-pregnancy obesity were associated with earlier age at menarche. If these factors related to SGA itself, could there be evidence of mediation?

Introduction:

Early menarche is defined as before age 10.5y (line 47) but before age 11y in this manuscript; it is worth distinguishing the reasons.

Line 52 – The implied causal association between early menarche and mental health problems and antisocial behaviors is potentially fraught – adverse socioeconomic circumstances might explain both. The authors should either outline more about what is known about causality and/or make sure to differentiate.

Methods:

There is a fair number of missing measurements (859 out of a starting 2,295) – can the authors comment on any differences between those newborns with versus without available data (presumably maternal information at enrollment may be available)?

What do the authors make of the finding that 10-11.6% of their sample was SGA (depending on measurement technique used)? This proportion is aligned with the expected proportion of <10% in the general population, even though their sample was designed to be enriched in individuals who might be expected to be at higher risk to have infants who are SGA?

Line 152: BMI is weight in kg divided by height in meters (not centimeters) squared

Results:

Present the differences between those included versus excluded from the sample in table form, i.e., include these details, since there were age and income differences.

Table 1 – should be presented in Results, and since this Table refers to the analysis cohort only, should be discussed after the in versus out of cohort.

-Age is reported in months to 2 significant digits. Suggest to 1 or no decimal points, and reporting 95% confidence intervals. See PMID 25877157. Suggest statistically significant differences between SGA and non-SGA be indicated in bold text.

-Formatting could be improved, e.g., to indicate explicitly categories for age.

Again, the nominal difference of 1 month in Line 96 should not be presented as a “difference” if not significant; if the authors choose to show this nominal difference, they should also show the 95% CI for the difference in the text (not just the table). Suggest revising number of decimal points. Line 214, same comment. Instead, they did not detect a difference.

Line 219 – “the association was even larger” – there are post hoc statistical tests that can discern if the coefficients are truly statistically different from each other, which given substantial overlap in confidence intervals they may not be. Suggest revising.

Table 2 could also be formatted such that categories (e.g., age, race, are more explicitly grouped would improve readability). Bold text for statistically significant associations would be helpful. Similar feedback for Table 3.

Discussion:

Line 264 – although the coefficient is nominally larger, there are specific statistical tests that are used to determine whether the coefficients are statistically different – were these done?

Overall, the results are situated in the existing literature. The Discussion would be enhanced by some more mechanistic insights from the literature underlying the epidemiologic associations observed.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Sep 6;19(9):e0309363. doi: 10.1371/journal.pone.0309363.r002

Author response to Decision Letter 0


27 Jul 2024

Please see document "Response to Reviewers" attached to submission. Pasted here without formatting:

Responses regarding journal requirements: (our responses are indicated by the bulleted arrow)

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf

and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

� We ensured that our manuscript meets PLOS ONE’s style requirements.

2. Thank you for stating the following financial disclosure:

“Support for this research was provided by award UL1TR003017 from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health and grant 74260 from the Robert Wood Johnson Foundation through its support of the Child Health Institute of New Jersey.”

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

� We added the suggested statement to the financial disclosure and included the revised financial disclosure in the cover letter, as directed.

3. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Boar d, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

� We included the following data availability statement in our cover letter:

We used third-party data that are available to the public through a restricted data use contact from the Future of Families & Child Wellbeing Study at Princeton University. Details about the application process can be found at: https://ffcws.princeton.edu/restricted.

Responses to Reviewers

� We thank the reviewers for the very helpful comments.

� Please note that in reanalyzing the data, we found that we were able to include a slightly larger number of cases in our analyses. This did not change any findings or interpretations. We also now focus exclusively on the measure of SGA that was based on LMP-based gestational age.

Reviewer #1: The article entitled “Small for gestational age and age at menarche in a contemporary population-based US sample” tested the hypothesis that SGA girls experience earlier menarche. Prior reports of racially homogenous populations have yielded mixed results. This analysis of a largely minority racial/ethnic population showed that maternal factors such as race/ethnicity and obesity influenced age of menarche, rather than SGA status. The data provides valuable information to add to our understanding of factors that influence pubertal onset.

Specific comments:

1. Please provide more context to the FFCWB study, that may explain the demographic of the study population.

� We now include the following paragraph on page 5, line 100:

The FFCWB cohort was population-based because it used a probability sample of cities, hospitals, and births within hospitals. Non-marital births were oversampled by design; that is, marital births were no longer included when hospital-specific quotas were reached. The reason for the oversampling was that unmarried parents and their children had been underrepresented in national U.S. datasets. About three-fourths of the mothers in the study were unmarried when they gave birth [25,26]. Because non-marital childbearing is strongly associated with poverty in the U.S., as is racial/ethnic minority status, the FFCWB sample had high fractions of poor, Black, and Hispanic parents.

2. The paragraph describing SGA (lines 113 to 125) was confusing. Line 114 – please clarify. Are the authors referring to determination of the gestational age? It’s also unclear why two different methods were needed to define SGA. subjects used the LMP vs the records-based measure.

� We edited and clarified the paragraph describing SGA (page 6, line 116). We had been referring to the determination of gestational age, but that should be clear in the revised text, which now reads as follows:

SGA was defined as <10th percentile of sex-specific birth weight for gestational age. Gestational age was calculated as the number of completed weeks between the date of the first day of the mother’s last menstrual period (LMP) and the child’s birthday. The respondent’s birth weight for gestational age was compared to the national U.S. sex-specific reference distribution of LMP-based SGA from 1999–2000[28] when most of the FFCWB sample members were born.

� Please note that we now focus exclusively on the measure of SGA that used LMP-based gestational age.

3. Lines 177/178: Is it the controls that were limited to births that were NOT low birthweight?

� We clarified the text to indicate that we restricted the sample to children that weighed more than 2500 grams at birth in those analyses.

4. In Results, I recommend describing the difference in race/ethnicity between SGA vs not SGA.

� Please see the following sentence on line 212 of the revised paper (bolding is for emphasis here):

Compared to girls who were not SGA, those who were SGA were more likely to have mothers who were non-Hispanic Black (60% vs. 48%), had Medicaid-financed births (76% vs. 63%), and smoked during pregnancy (44% vs. 21%), and were less likely to have mothers who were Hispanic (19% vs. 28%) and married (14% vs. 26%).

4. Substantial discussion was given to the effect of obesity on early menarche but there was almost no discussion given for the effect of race/ethnicity on the same. Please elaborate on the current understanding of the relationship between race/ethnicity and pubertal timing (including if relevant, early childhood stress, environmental racism, Pediatrics (2022) 150 (2): e2021055595. https://doi.org/10.1542/peds.2021-055595).

� We elaborated on the current understanding of the relationship between race/ethnicity and pubertal timing, bringing in the suggested article (line 288). We agree that this relationship was underdiscussed in the previous version of the paper.

Reviewer #2: The Authors hereby report the menarche onset in a pediatric cohort of small for gestational age females. The data are of interest and the cohort has a quite adequate dimension. There are two main concerns about this paper:

1. Table 1 should be moved into the Results sections, p column should be added in the right and not reported in legend

� Done.

2. Why Authors chose 11 years old as a cut off for menarche? Precious menarche is considered as before 10 years-old, thus all considerations about whether SGA newborn females have precocious menarche more frequently rather than non-SGA should be done considering the 10 years-old cut-off.

� As we now indicate on line 51, no standard cut-off has been used in the literature; cut-offs have ranged from 10.5 to 12 and age 11 has been used in other studies (line 132). That said, we estimated supplementary models with age 10 as the cutoff (menarche before age 10), but with only 38 girls in our sample with early menarche defined this way, we were not able to estimate adjusted models. In the unadjusted models, SGA was not significantly associated with age in months at menarche or early menarche. We now point to not being able to use a more stringent cut-off as a limitation of our study (line 342).

� Also, please note that we now focus exclusively on the measure of SGA that uses LMP-based gestational age.

Reviewer #3: Well written with statistics supporting the results. Also the arguments and rationale is well supported with references. Population sample is also presentation of contemporary US population. Overall good addition to the current literature.

� Thank you.

Reviewer #4: General comments: Sources of variation in age at menarche are a useful focus of investigation. The authors did not find associations between SGA and age at menarche. They did identify a number of other maternal factors related to age at menarche. The data are overall presented clearly, though there are some opportunities to improve formatting and readability suggested below, as well as questions regarding some of the statements (e.g., when the authors compare the value of two coefficients).

1. Did the authors have any other health information about the girls at follow up (e.g., BMI) that also could yield more information, even if they did not have information about catch-up growth patterns?

� We now report on supplemental results from models that interacted SGA and weight gain between birth and one year (line 262):

In supplementary models that interacted weight gain between birth and age 1 with SGA, we found no significant interactions. However, weight gain was associated with earlier menarche in those models (e.g., OLS coeff: -.75; CI: -1.36, -0.15) in the fully adjusted model for age at menarche in months and AOR: 1.13; CI: 1.02, 1.26 in the fully adjusted model for menarche before age 11) (not shown in tables).

� Unfortunately, we do not have better health data to use for this supplementary analysis.

2. Sex differences are also interesting – can the authors also speculate as to the differences, if any, between maternal factors and pubertal outcomes in female infants as compared to male infants?

� We now point to not being able to study linkages between SGA and puberty for males as a limitation of our study (line 344).

3. Abstract: The database consisting of mostly of non-marital births may not be representative of the U.S. population; the authors should comment in the Discussion on how their results may differ. That said, with this current focus, the database may teach us more about children deserving of additional study.

� We now indicate in the abstract that the sample consisted of mostly non-marital births and highlight that it represents a policy-relevant population in the U.S. We elaborate on this point when commenting on the strengths and limitations of the study in the Discussion (line 326).

4. The authors describe “early menarche” as before age 11 years. Care should be taken to distinguish between “early menarche” (variation of typical) and “premature menarche” (implying the possibility of pathology).

� We now make this distinction (line 53).

5. If the difference was not statistically significant, then the authors should not write “SGA was associated with slightly earlier menarche” which implies some meaningful difference. Instead, they can write, e.g., “We did not detect a difference.”

� We changed the wording throughout to avoid such language.

6. The authors conclude that maternal non-Hispanic black race-ethnicity, Hispanic ethnicity, and pre-pregnancy obesity were associated with earlier age at menarche. If these factors related to SGA itself, could there be evidence of mediation?

� This was an interesting comment. We ran supplementary models that did not include SGA to assess how much of a difference including SGA in the models affected the estimates for maternal non-Hispanic black race-ethnicity, Hispanic ethnicity, and pre-pregnancy obesity. We found that the estimates for all of these factors were very similar to those shown in the main models, suggesting no mediation. We could not find a straightforward way to motivate these supplementary analyses in the “supplementary analyses” section, so we ended up not reporting on these interesting supplementary results.

7. Early menarche is defined as before age 10.5y (line 47) but before age 11y in this manuscript; it is worth distinguishing the reasons.

� As we now indicate on line 51, no standard cut-off has been used in the literature; cut-offs have ranged from 10.5 to 12 and age 11 has been used in other studies (line 132). That said, we estimated supplementary models with age 10 as the cutoff (menarche before age 10), but with only 38 girls in our sample with early menarche defined this way, we were not able to estimate adjusted models. In the unadjusted models, SGA was not significantly associated with age in months at menarche or early menarche. We now point to not being able to use a more stringent cut-off as a limitation of our study (line 342).

8. Line 52 – The implied causal association between early menarche and mental health problems and antisocial behaviors is potentially fraught – adverse socioeconomic circumstances might explain both. The authors should either outline more about what is known about causality and/or make sure to differentiate.

� We now make this important point as follows on line 56:

Further, girls with early menarche are more likely to experience depressive symptoms and engage in health risk behaviors that adversely impact health in adulthood[7], although it has not been established whether those associations are confounded by socioeconomic factors.

9. There is a fair number of missing measurements (859 out of a starting 2,295) – can the authors comment on any differences between those newborns with versus without available data (presumably maternal information at enrollment may be available)?

� Done. This information is now presented in S1 Table.

10. What do the authors make of the finding that 10-11.6% of their sample was SGA (depending on measurement technique used)? This proportion is aligned with the expected proportion of <10% in the general population, even though their sample was designed to be enriched in individuals who might be expected to be at higher risk to have infants who are SGA?

� We now focus exclusively on the analyses based on LMP-based gestational age. Using that measure, 11.7% of our sample was SGA and we highlight that this figure is expectedly higher than in the general population because of the largely disadvantaged population we studied (line 329).

11. Line 152: BMI is weight in kg divided by height in meters (not centimeters) squared

� We corrected this typographical error.

12. Present the differences between those included versus excluded from the sample in table form, i.e., include these details, since there were age and income differences.

� Done. We now present this information in S1 Table for all of the variables that are in our analyses.

13. Table 1 – should be presented in Results, and since this Table refers to the analysis cohort only, should be discussed after the in versus out of cohort.

� Done.

14. Age is reported in months to 2 significant digits. Suggest to 1 or no decimal points, and reporting 95% confidence intervals. See PMID 25877157. Suggest statistically significant d

Attachment

Submitted filename: Response to Reviewers.docx

pone.0309363.s002.docx (30KB, docx)

Decision Letter 1

Inge Roggen

6 Aug 2024

PONE-D-24-13471R1Small for gestational age and age at menarche in a contemporary population-based U.S. samplePLOS ONE

Dear Dr. Sabu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please address these two minor (last) comments:1. Line 248/249: As there was no statistically significant difference in menarche age between SGA and non-SGA, the statement should be modified to state “There was no difference in early menarche between girls who were SGA vs. non-SGA.”

2. Please confirm in Table 2, for Adjusted maternal demographics, for Hispanic race ethnicity, if the upper CI is 3.61 or -3.61.

Please submit your revised manuscript by Sep 20 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Inge Roggen, M.D., Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The responses to prior comments have been adequately addressed. I have two minor comments:

1. Line 248/249: As there was no statistically significant difference in menarche age between SGA and non-SGA, the statement should be modified to state “There was no difference in early menarche between girls who were SGA vs. non-SGA.”

2. Please confirm in Table 2, for Adjusted maternal demographics, for Hispanic race ethnicity, if the upper CI is 3.61 or -3.61.

Reviewer #3: Author has responded to all the comments and the study add good contribution to the literature in maternal and child health domain.

Reviewer #4: From above: If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: Yes: Rabia Baloch

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Sep 6;19(9):e0309363. doi: 10.1371/journal.pone.0309363.r004

Author response to Decision Letter 1


8 Aug 2024

Pasted without formatting:

1. Line 248/249: As there was no statistically significant difference in menarche age between SGA and non-SGA, the statement should be modified to state “There was no difference in early menarche between girls who were SGA vs. non-SGA.”

� The line number listed by the reviewer did not correlate to a relevant sentence. But we noted a similar statement earlier in our paper. We made this change (line 197-198) that now reads:

There was no difference in age at menarche between girls who were born SGA vs. those who were not born SGA.

2. Please confirm in Table 2, for Adjusted maternal demographics, for Hispanic race ethnicity, if the upper CI is 3.61 or -3.61.

� Thank you for catching this typo. The upper CI should be -3.61. We made this change.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0309363.s003.docx (15.3KB, docx)

Decision Letter 2

Inge Roggen

12 Aug 2024

Small for gestational age and age at menarche in a contemporary population-based U.S. sample

PONE-D-24-13471R2

Dear Dr. Sabu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Inge Roggen, M.D., Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Inge Roggen

27 Aug 2024

PONE-D-24-13471R2

PLOS ONE

Dear Dr. Sabu,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Inge Roggen

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Comparison of analysis sample to singleton female births not in the sample.

    Notes: Calculations are based on sample used for analyses of age at menarche in months. P-values are for differences between those in the sample for age at menarche in months and singleton females not in that sample at the 5% level using a two-tailed t-test (statistically significant p-values in bold).

    (DOCX)

    pone.0309363.s001.docx (17.1KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0309363.s002.docx (30KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0309363.s003.docx (15.3KB, docx)

    Data Availability Statement

    Data availability statement: We used third-party data that are available to the public through a restricted data use contract from the Future of Families & Child Wellbeing Study at Princeton University. Details about the application process can be found at: https://ffcws.princeton.edu/restricted.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES